Therapeutic drug monitoring of immunosuppressants by liquid chromatography–mass spectrometry

This publication has 55 references indexed in Scilit:

• Comparison between ultra-performance liquid chromatography with tandem mass spectrometry and a chemiluminescence immunoassay in the determination of cyclosporin A and tacrolimus levels in whole blood
  Experimental and Therapeutic Medicine, 2013
• Validation of an LC-MS/MS method to determine five immunosuppressants with deuterated internal standards including MPA
  BMC Clinical Pharmacology, 2012
• Evaluation of the Abbott ARCHITECT i2000 Sirolimus Assay and Comparison With the Abbott IMx Sirolimus Assay and an Established Liquid Chromatography–Tandem Mass Spectrometry Method
  Therapeutic Drug Monitoring, 2011
• The interactions of age, genetics, and disease severity on tacrolimus dosing requirements after pediatric kidney and liver transplantation
  European Journal of Clinical Pharmacology, 2011
• Evaluation of QMS Everolimus Assay Using Hitachi 917 Analyzer: Comparison With Liquid Chromatography/Mass Spectrometry
  Therapeutic Drug Monitoring, 2011
• Ultra Fast Liquid Chromatography-Tandem Mass Spectrometry Routine Method for Simultaneous Determination of Cyclosporin A, Tacrolimus, Sirolimus, and Everolimus in Whole Blood Using Deuterated Internal Standards for Cyclosporin A and Everolimus
  Therapeutic Drug Monitoring, 2010
• Cyclosporine monitoring in the early post-transplant period in pediatric liver transplant recipients
  Pediatric Transplantation, 2007
• Everolimus and Reduced-Exposure Cyclosporine in de novo Renal-Transplant Recipients: A Three-Year Phase II, Randomized, Multicenter, Open-Label Study
  Transplantation, 2004
• The Influence of Sex on Pharmacokinetics
  Clinical Pharmacokinetics, 2003
• Therapeutic drug monitoring of immunosuppressant drugs
  British Journal of Clinical Pharmacology, 1999